# Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

> **NCT00158470** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 100 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** efavirenz
- **DRUG:** didanosine
- **DRUG:** lamivudine

## Key facts

- **NCT ID:** NCT00158470
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2007-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158470, "Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00158470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*